News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nycomed to Market Roche (RHHBY) Osteoporosis Drug in China and Asia-Pacific


6/15/2011 10:34:23 AM

June 15, 2011 -- Nycomed, the Swiss biopharma, will market a Roche osteoporosis treatment, Bonviva, in China and other Asia Pacific markets. Boniva, a bisphosphonate, will be added to Nycomed’s existing portfolio of osteoporosis products. Nycomed, the 28th largest biopharma in the world, generates the highest proportion of its revenues from developing countries of any large or medium-sized global pharma – an unusual metric – though China is not one of its top five markets. More details....

Stock Symbol: (VS: ROG)


Read at ChinaBio Today

comments powered by Disqus
Nycomed
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES